Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
収録刊行物
-
- The Lancet Oncology
-
The Lancet Oncology 14 (8), 697-710, 2013-07
Elsevier BV